Please login to the form below

Not currently logged in
Email:
Password:

Biogen promotes Matt Griffiths to chief information officer

He originally joined the firm from Dell earlier this year

Biogen has appointed Matt Griffiths as senior vice president and chief information officer.

The move is a promotion for Griffiths, who joined Biogen earlier this year from Dell as VP of pharmaceutical operations and corporate information technology.

In his new role, Griffiths will aim to develop the company's overall strategy for enterprise IT, including business engagement, global solution development and support and infrastructure, while supporting the core business and growing pipeline.

Adriana Karaboutis, executive VP of technology and business solutions at Biogen, commented: “Matt's technical expertise, background in analytics and business solutions, and his ability to bridge disparate organisations and disciplines will be critical as technology plays an increasingly important role at Biogen.

“As we continue to advance the development of new therapeutic candidates and gain insights from existing treatments, our ability to harness data becomes increasingly important. I am excited to work with Matt to advance the remarkable opportunities before us.”

Prior to joining Biogen, Griffiths spent 16 years at Dell where he held numerous IT roles in Europe and the US. 

He additionally serves on the Pharmaceutical Information Systems Association (PISA), a non-profit organisation that shares information and IT best practices across biotech and pharma firms to further the industry' capabilities.

21st May 2015

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Madmicrobe Studios

MadMicrobe is an award-winning team of certified medical illustrators creating animations that draw audiences into a world of suspense, excitement,...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics